| div class="googleright"> | | | | these are short-term and do not cause great harm |
| In the billion dollar drug industry, the race is on | | | | to the user. However, in some rare cases, the drugs |
| between pharmaceutical companies to bring the next | | | | can cause certain adverse reactions, that can cause |
| wonder drug into the market, in the shortest possible | | | | grievous damage to the user or at times, even result |
| time in order to earn better before the patent | | | | in death. All drug manufacturers are required to take |
| expires. But Research and Development takes in a lot | | | | into account the adverse effects caused by their |
| of time. So does clinical trials, manufacturing and | | | | drugs, right from the product development stage till |
| marketing of drugs. But amidst all this, companies | | | | after the post-marketing phase. Regulatory |
| have to grapple with another big challenge - the | | | | authorities such as the FDA have stringent rules that |
| tracking of adverse events caused by the drugs. | | | | drug manufacturers and marketers need to follow in |
| Almost all drugs have some side-effects. Most of | | | | order to manage safety risks from drugs. |